* Biotricity Inc BTCY.OQ BTCY.O is expected to show a
rise in
quarterly revenue when it reports results on August 15.
* The Redwood City California-based company is expected to
report
a 24.0% increase in revenue to $2.188 million from $1.76
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Biotricity Inc is
for a
loss of 11 cents per share. For the same quarter last year, the
company reported a loss of 9 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Biotricity
Inc is
$3, above its last closing price of $1.20.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2022 -0.11 -0.11 Met 0
Dec. 31 2022 -0.17 -0.16 -0.12 Beat 27.3
Sep. 30 2021 -0.11 -0.10 -0.14 Missed -40
Jun. 30 2021 -0.09 -0.09 -0.09 Met 0
This summary was machine generated August 12 at 21:55 GMT. All
figures in US dollars unless otherwise stated